CaƱete, Liezel .
HRN: 25-30-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2024
CEFUROXIME 1.5GM (VIAL)
06/17/2024
06/18/2024
IV
1.5
Q8 X 3 Doses
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes